Tag: pharmaceuticals
-

Trial to Test Convalescent Antibodies for Covid-19
A group of Canadian academic labs and hospitals will begin a clinical trial testing antibodies from recovered Covid-19 patients as a treatment for the disease.
-

Trial to Test Electronic-Aided Covid-19 Vaccine
A company developing cancer immunotherapies is adapting its electronic-assisted process to create a vaccine protecting against Covid-19 infections.
-

Employers, Patients See Discounts from Biosimilars
An analysis of health care spending by large employers shows both companies and their employees are saving money from using non-branded biologic therapies.
-

Life Science Venture Funds Raise $2.56B for Start-Ups
Two investment companies specializing in health care and life sciences revealed new venture funds to finance young enterprises with innovative technologies.
-

Trial to Test Malaria Drug to Stop Covid-19
A registry and clinical trial of health care workers aims to document effects of hydroxychloroquine, a widely available malaria drug, to prevent Covid-19 infections.
-

Trial Shows Rare Disease Drug Treats Covid-19 Patients
Results from a clinical trial show a drug approved for a rare lymph node disease can stabilize or improve the condition of many people with severe Covid-19 complications.
-

Start-Up Licenses Immunotherapies in $880M Deal
A new biotechnology enterprise creating treatments that alter chemical functions in immune cells agreed to license its technology to a pharmaceutical company.
-

Biotechs Explore Cell Therapy for Covid-19 Antibodies
Two biotechnology companies are researching use of a non-viral gene therapy to deliver synthetic antibodies for treating Covid-19 infections.
-

Sanofi, Biotech Partner on RNA Covid-19 Vaccine
Drug maker Sanofi and biotechnology company Translate Bio are creating a new vaccine to protect against the virus causing Covid-19 infections
-

Consortium to Find Neutralizing Viral Antibodies
A coalition of business and academic labs is creating a process to quickly identify antibodies in blood samples that neutralize viruses like SARS-CoV-2.